Literature DB >> 13315897

Intermediate stages in the formation of blood thromboplastin.

D E BERGSAGEL, C HOUGIE.   

Abstract

Keywords:  THROMBOPLASTIC SUBSTANCES

Mesh:

Substances:

Year:  1956        PMID: 13315897     DOI: 10.1111/j.1365-2141.1956.tb06820.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

1.  The thrombotic activity of activation product.

Authors:  E S HENDERSON; S L RAPAPORT
Journal:  J Clin Invest       Date:  1962-02       Impact factor: 14.808

2.  Increase in antihaemophilic globulin activity following infusion of adrenaline.

Authors:  G I INGRAM
Journal:  J Physiol       Date:  1961-04       Impact factor: 5.182

3.  [Differential diagnostic difficulties in a case of hemophilia A].

Authors:  H POLIWODA
Journal:  Klin Wochenschr       Date:  1959-11-01

4.  Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency.

Authors:  C HOUGIE; E M BARROW; J B GRAHAM
Journal:  J Clin Invest       Date:  1957-03       Impact factor: 14.808

5.  The Role of Proaccelerin in Human Blood Coagulation. Evidence that Proaccelerin Is Converted to a Prothrombin-converting Principle by Activated Stuart Factor: With Notes on the Anticoagulant Action of Soybean Trypsin Inhibitor, Protamine Sulfate, and Hexadimethrine Bromide.

Authors:  R T Breckenridge; O D Ratnoff
Journal:  J Clin Invest       Date:  1965-02       Impact factor: 14.808

6.  Effects of bacterial endotoxin on rabbit platelets. I. Platelet aggregation and release of platelet factors in vitro.

Authors:  R M DES PREZ; H I HOROWITZ; E W HOOK
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307

7.  Effects of bacterial endotoxin on rabbit platelets. II. Enhancement of platelet factor 3 activity in vitro and in vivo.

Authors:  H I HOROWITZ; R M DES PREZ; E W HOOK
Journal:  J Exp Med       Date:  1962-11-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.